Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

Name:	us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Commitments and Contingencies - Contingent Consideration (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024	Apr. 30, 2024
Commitments And Contingencies
Exarafenib milestone contingent consideration	$ 3,307	$ 3,214
CVR Agreement \| Kinnate CVR holders
Commitments And Contingencies
Exarafenib milestone contingent consideration	$ 3,300		$ 2,900